We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Research Partnership to Advance Genomics and Bioinformatics Technology

By LabMedica International staff writers
Posted on 06 Feb 2012
Print article
A new collaboration using high-performance pipeline automation technology has been initiated to accelerate next-generation sequencing and bioinformatics capabilities. Moreover, the collaborative program supports the advancement of bioinformatics, genetic pipelines, and applied high-performance computing.

Appistry, Inc. (St. Louis, MO, USA), a company focused on solving complex, data intensive problems, announced a strategic partnership with the University of Missouri (UM; Columbia, USA) to enhance the school’s genomic research. Through the partnership, the University of Missouri will deploy Ayrris/BIO, Appistry’s high-performance pipeline automation system.

Through the UM Bioinformatics Consortium, a resource for high-performance computational infrastructure geared toward facilitating intercampus communication and bioinformatics research collaborations, the University of Missouri has emerged as the Midwest’s leading innovator in genomic research and data analysis. While the university’s agricultural genomics research continues to create perceptive returns, with computational data storage nearing capacity, the deployment of a data life cycle management system emerged as a requirement. Appistry’s computational storage technology will remove data logjams and manage workloads while enabling downstream bioinformatics at scale.

As part of the partnership, Appistry’s technologies will enable the University of Missouri to construct, manage, and execute high throughput computing techniques to develop new pipelines for accurate, cost-effective, and high quality analysis of genomic data. The University of Missouri will deploy the Ayrris/BIO high-performance computing platform to increase the computational range of their automated sequencing pipelines and alleviate their data management burden. The early research projects using the appliance will be focused on plant and animal genomics work that is ongoing at the MU campus.

“We are really excited about the opportunities that this partnership with Appistry brings to the University,” commented Gordon Springer, PhD, department of computer science scientific director, at University of Missouri Bioinformatics Consortium. “Our ability to quickly and efficiently carry out the early and secondary analysis of sequence data to answer important questions about plant, animal, and human genomics problems with new state of the art technologies is like the opening of a new bridge on the path to discovery. Where we end up is unknown, but that’s what makes it so exciting; to be able to discover new things about ourselves and nature.”

“The opportunity to partner with our state’s most influential research and academic organization is not only thrilling--it’s a critical development for the advancement of bioinformatics and next-generation sequencing,” said Kevin Haar, CEO of Appistry. “Regional collaborations like this are necessary to accelerate innovation in life sciences and to complete the life cycle of genomic research and analysis in order to support the advancement of personalized medicine and other medical breakthroughs.”

Related Links:
Appistry
University of Missouri


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.